Pfizer (PFE) Receivables (2009 - 2026)
Pfizer (PFE) reported Receivables of $12.49 billion for Q2 2026, up 3.4% from $12.08 billion a year earlier but down 0.8% from the prior quarter.
Powered by 
Analysis
Pfizer (PFE) Receivables (2009 - 2026) Analysis & Trends
At the end of FY2025, Pfizer posted Receivables of $11.87 billion, up 3.6% from FY2024.
- Receivables has a five-year compound annual growth rate of 7.4% (FY2020 to FY2025).
- By year, Receivables came in at $11.46 billion in FY2024 (-0.9%), $11.57 billion in FY2023 (+5.6%), $10.95 billion in FY2022 (-5.0%) and $11.53 billion in FY2021 (+38.7%).
- Five-year quarterly Receivables spans a low of $10.23 billion in Q2 2023 and a high of $15.43 billion in Q2 2022.
- Year over year, Receivables has now increased in each of the last three quarters, with growth averaging 3.5% over the last seven quarters.
- The high point for year-over-year Receivables in five years was Q2 2022 (growth of 40.0%); the low point was Q2 2023 (a decline of 33.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $12.59 billion (Q1 2026), $11.87 billion (Q4 2025) and $14.26 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Vertex Pharmaceuticals | 135.25 Bn | 107.26 Bn | 2.84 Bn | 2.13 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 12.49 Bn |
| Mar 29, 2026 | 12.59 Bn |
| Dec 31, 2025 | 11.87 Bn |
| Sep 28, 2025 | 14.26 Bn |
| Jun 29, 2025 | 12.08 Bn |
| Mar 30, 2025 | 11.85 Bn |
| Dec 31, 2024 | 11.46 Bn |
| Sep 29, 2024 | 14.45 Bn |
| Jun 30, 2024 | 11.39 Bn |
| Mar 31, 2024 | 10.99 Bn |
| Dec 31, 2023 | 11.57 Bn |
| Oct 1, 2023 | 11.09 Bn |
| Jul 2, 2023 | 10.23 Bn |
| Apr 2, 2023 | 12.36 Bn |
| Dec 31, 2022 | 10.95 Bn |
| Oct 2, 2022 | 16.24 Bn |
| Jul 3, 2022 | 15.43 Bn |
| Apr 3, 2022 | 13.36 Bn |
| Dec 31, 2021 | 11.53 Bn |
| Oct 3, 2021 | 12.09 Bn |
API Access
Pfizer Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();